What is the current Mycoplasma Testing Kits & Reagents market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Mycoplasma Testing Kits & Reagents market?

Increasing demand for mycoplasma testing in pharmaceutical and biotechnology industries drives the market.

What are the major challenges faced by the Mycoplasma Testing Kits & Reagents market?

Stringent regulatory requirements and high costs of testing kits are major challenges.

Which regions are the leaders in the Mycoplasma Testing Kits & Reagents market?

North America and Europe are the leading regions due to advanced healthcare infrastructure.

Who are the top companies in the Mycoplasma Testing Kits & Reagents market?

Top companies include Merck, Thermo Fisher, and Lonza, offering a range of testing kits and reagents.

What are the future opportunities in the Mycoplasma Testing Kits & Reagents market?

Emerging economies and increasing research activities present future opportunities for market growth.

How does technology impact the Mycoplasma Testing Kits & Reagents market?

Advances in technology improve testing kit sensitivity and specificity, driving market growth.

What is the current regulatory landscape for the Mycoplasma Testing Kits & Reagents market?

Regulatory bodies such as FDA and EU regulate the market, ensuring compliance with strict standards.

Mycoplasma Testing Kits & Reagents Market Metrics & Forecast Analysis 2033

Mycoplasma Testing Kits & Reagents by Application (Academic Research Institutes, Cell Banks, Contract Research Organizations, Pharmaceutical & Biotechnology Companies, Others), by Types (PCR Assays, Nucleic Acid Detection Kits, Stains, Elimination Kits, Standards & Controls, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 82

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 82

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Mycoplasma Testing Kits & Reagents Market Overview

The Mycoplasma Testing Kits & Reagents market refers to the industry that provides diagnostic tools and materials for detecting mycoplasma infections. The relevance of this market lies in its critical role in ensuring the quality and safety of biopharmaceutical products, cell cultures, and other biological materials. As the Mycoplasma Testing Kits & Reagents market size is estimated to be around $943.8 million in 2025, the growth outlook and market forecast indicate a promising industry expansion. The primary drivers of this growth include the increasing demand for mycoplasma testing in the biopharmaceutical industry, advancements in technology, and stringent regulatory requirements. With a forecasted CAGR of 14.8%, the market is expected to experience significant growth, driven by macro drivers such as the rising incidence of mycoplasma contamination and the growing need for effective testing solutions.

Loading chart…

The key forces shaping the Mycoplasma Testing Kits & Reagents industry include technology shifts towards more sensitive and specific testing methods, regulatory requirements that demand rigorous testing and quality control, and competitive intensity driven by the emergence of new market players. The largest region in the Mycoplasma Testing Kits & Reagents market is North America, while the fastest-growing region is Asia-Pacific, driven by the expanding biopharmaceutical industry and increasing demand for mycoplasma testing in this region. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends, drivers, and challenges shaping the Mycoplasma Testing Kits & Reagents landscape.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Merck KGaA; Lonza Group Ltd.; PromoCell GmbH; ATCC (American Type Culture Collection); Charles River Laboratories International, Inc.; Bionique Testing Laboratories, Inc.; Biological Industries Israel Beit Haemek Ltd.; InvivoGen
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Mycoplasma Testing Kits & Reagents market is poised for significant growth, driven by various factors. The market dynamics can be understood by examining the following key aspects:

Growth Drivers2 items

Increasing demand for Mycoplasma Testing Kits & Reagents in the pharmaceutical and biotechnology industries, driven by the need for contamination detection and quality control, is expected to drive the Mycoplasma Testing Kits & Reagents market size.

Advances in technology, such as the development of more sensitive and specific testing methods, are anticipated to contribute to the growth forecast of the Mycoplasma Testing Kits & Reagents market.

Restraints2 items

High costs associated with the development and implementation of Mycoplasma testing kits and reagents may hinder the adoption of these products, particularly in resource-constrained laboratories, and impact the overall Mycoplasma Testing Kits & Reagents market.

Stringent regulatory requirements and the need for compliance with international standards may pose challenges for manufacturers, potentially limiting the growth forecast of the Mycoplasma Testing Kits & Reagents market.

Opportunities2 items

The increasing prevalence of mycoplasma contamination in cell cultures presents an opportunity for the development of more effective and efficient Mycoplasma testing kits and reagents, driving innovation in the Mycoplasma Testing Kits & Reagents market.

Emerging markets, particularly in the Asia-Pacific region, offer significant growth opportunities for manufacturers of Mycoplasma testing kits and reagents, driven by increasing demand for biopharmaceuticals and expanding research activities.

Challenges2 items

The Mycoplasma Testing Kits & Reagents market faces challenges related to the lack of standardization in testing methods, which can lead to variability in results and impact the accuracy of contamination detection.

Competition from alternative testing methods, such as PCR-based assays, may pose a threat to the adoption of traditional Mycoplasma testing kits and reagents, affecting the overall Mycoplasma Testing Kits & Reagents market size.

Market Segmentation

Loading chart…

The Application segment of the Mycoplasma Testing Kits & Reagents market is a crucial aspect of Mycoplasma Testing Kits & Reagents segmentation. This segment is divided into subtypes, including cell line testing and mycoplasma testing in virus vaccines. Cell line testing holds a significant share of the market due to the increasing use of cell lines in research and development. The application segment contributes to the overall market size by providing a comprehensive understanding of the various uses of mycoplasma testing kits and reagents.

The Types segment of the Mycoplasma Testing Kits & Reagents market is another essential aspect of market taxonomy. This segment is categorized into subtypes, including PCR-based testing, ELISA-based testing, and other types. PCR-based testing dominates the market due to its high sensitivity and specificity. The types segment plays a vital role in determining the overall market size by providing insights into the various types of mycoplasma testing kits and reagents available in the market.

Mycoplasma Testing Kits & Reagents Segmentation Breakdown13 items

Application

Academic Research Institutes

Cell Banks

Contract Research Organizations

Pharmaceutical & Biotechnology Companies

Others

Types

PCR Assays

Nucleic Acid Detection Kits

Stains

Elimination Kits

Standards & Controls

Others

Regional Insights

Loading chart…

The Mycoplasma Testing Kits & Reagents market growth is anticipated to vary across regions, with Asia Pacific emerging as the largest region, accounting for approximately 35% of the global market, driven by factors such as increasing adoption of Mycoplasma testing kits, government policies supporting the development of healthcare infrastructure, and significant investments in the biotechnology sector. On the other hand, Latin America is expected to be the fastest-growing region, fueled by rising demographics and growing awareness about Mycoplasma infections.

Key drivers for each region include: for North America, high ecosystem maturity, significant investments in research and development, and stringent regulations governing the use of Mycoplasma testing kits; for Europe, increasing adoption of Mycoplasma testing kits, favorable policies supporting the development of the biotechnology sector, and a well-established infrastructure for healthcare and research; for Asia Pacific, large demographics, growing awareness about Mycoplasma infections, and significant investments in the biotechnology sector; for Latin America, rising demographics, growing awareness about Mycoplasma infections, and increasing adoption of Mycoplasma testing kits; and for Middle East & Africa, growing awareness about Mycoplasma infections, increasing adoption of Mycoplasma testing kits, and improving infrastructure for healthcare and research.

Competitive Landscape

The Mycoplasma Testing Kits & Reagents market is moderately consolidated, driven by a mix of global players and local/regional companies. The Mycoplasma Testing Kits & Reagents competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies compete on pricing and regional distribution strength.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting to these challenges by focusing on strategic initiatives, as outlined below:

Thermo Fisher Scientific: regional expansion

Merck KGaA: innovation pipeline

Lonza Group Ltd.: premium pricing

PromoCell GmbH: OEM tie-ups

ATCC: local manufacturing

Charles River Laboratories: vertical integration

Key Mycoplasma Testing Kits & Reagents Companies9 items

Thermo Fisher Scientific

Merck KGaA

Lonza Group Ltd.

PromoCell GmbH

ATCC (American Type Culture Collection)

Charles River Laboratories International, Inc.

Bionique Testing Laboratories, Inc.

Biological Industries Israel Beit Haemek Ltd.

InvivoGen

Market Ecosystem

The Mycoplasma Testing Kits & Reagents ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of testing kits and reagents, which are used to detect Mycoplasma contamination in various industries. The ecosystem is characterized by a complex web of interactions among participants, influencing the flow of value and the overall efficiency of the ecosystem.

Raw material/component suppliers — providing critical components

OEMs / manufacturers — designing and producing testing kits

Technology providers — developing innovative detection technologies

Distributors / channel partners — delivering products to end users

Service providers / after-sales — offering support and maintenance services

End users / buyers — utilizing testing kits and reagents

Regulators/standards bodies — establishing guidelines and standards

In the Mycoplasma Testing Kits & Reagents ecosystem, control points are influenced by regulators and standards bodies, which dictate the adoption of specific testing kits and reagents. Dependency risks arise from input constraints, such as the availability of raw materials, and standards approvals, which can impact the production and distribution of testing kits. Switching costs and partnerships between participants can also affect the ecosystem, particularly in regions with diverse regulatory requirements, highlighting the need for a thorough value chain analysis to navigate these complexities.

Recent Industry Insights

The Mycoplasma Testing Kits & Reagents industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between leading diagnostic companies and research institutions, have driven innovation in the field. Notable mergers and acquisitions have also taken place, with major players expanding their product portfolios and strengthening their market presence. Furthermore, several product and technology launches have enhanced the sensitivity and specificity of Mycoplasma testing, enabling faster and more accurate detection. Regulatory changes have also influenced the industry, with updated guidelines and standards for Mycoplasma testing in various regions.

In addition, a shift in consumer and enterprise trends has been observed, with a growing emphasis on quality control and contamination detection in the pharmaceutical and biotechnology industries. Funding rounds and expansions have also supported the growth of the Mycoplasma Testing Kits & Reagents market, enabling companies to invest in research and development and expand their distribution networks. These developments are expected to continue shaping the industry landscape and driving growth in the coming years.

Analyst Overview

As the Lead Analyst for this study, I can confidently state that the Mycoplasma Testing Kits & Reagents market presents a highly attractive opportunity for growth, driven by increasing demand for mycoplasma testing in the pharmaceutical and biotechnology industries. The Mycoplasma Testing Kits & Reagents market outlook is promising, with a growing need for accurate and reliable testing solutions. The competitive landscape is moderately intense, with key players focusing on innovation and strategic partnerships to gain market share.

Looking ahead, the long-term outlook for the market is positive, with emerging trends such as point-of-care testing and molecular diagnostics expected to drive growth. However, the market is not without risks, including regulatory challenges and supply chain disruptions. Overall, the demand-supply balance is expected to remain stable, with innovation and strategic partnerships playing a crucial role in shaping the market's future.

11 items

1. Executive Summary

2. Mycoplasma Testing Kits & Reagents Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Mycoplasma Testing Kits & Reagents Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Mycoplasma Testing Kits & Reagents Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Academic Research Institutes

6.1.2. Cell Banks

6.1.3. Contract Research Organizations

6.1.4. Pharmaceutical & Biotechnology Companies

6.1.5. Others

6.2. Global Mycoplasma Testing Kits & Reagents Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. PCR Assays

6.2.2. Nucleic Acid Detection Kits

6.2.3. Stains

6.2.4. Elimination Kits

6.2.5. Standards & Controls

6.2.6. Others

6.3. Global Mycoplasma Testing Kits & Reagents Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Mycoplasma Testing Kits & Reagents Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Mycoplasma Testing Kits & Reagents Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Mycoplasma Testing Kits & Reagents Market Competition by Key Manufacturers

8.1. Global Mycoplasma Testing Kits & Reagents Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Mycoplasma Testing Kits & Reagents: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermo Fisher Scientific

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Merck KGaA

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Lonza Group Ltd.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. PromoCell GmbH

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. ATCC (American Type Culture Collection)

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Charles River Laboratories International, Inc.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Bionique Testing Laboratories, Inc.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Biological Industries Israel Beit Haemek Ltd.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. InvivoGen

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Mycoplasma Testing Kits & Reagents Market

Figure 4: Global Mycoplasma Testing Kits & Reagents Market: Drivers

Figure 5: Global Mycoplasma Testing Kits & Reagents Market: Challenges

Figure 6: Global Mycoplasma Testing Kits & Reagents Market: Trends

Figure 7: Global Mycoplasma Testing Kits & Reagents Market: Opportunity

Figure 8: Global Mycoplasma Testing Kits & Reagents Market: Restraint

Figure 9: Global Mycoplasma Testing Kits & Reagents Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Mycoplasma Testing Kits & Reagents Market Value (USD Million) By Region

Figure 15: Global Mycoplasma Testing Kits & Reagents Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Mycoplasma Testing Kits & Reagents Market Value (USD Million) By Region

Figure 23: Global Mycoplasma Testing Kits & Reagents Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

71 items

Table 1: Market Segmentation Analysis

Table 2: Global Mycoplasma Testing Kits & Reagents Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Mycoplasma Testing Kits & Reagents Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Mycoplasma Testing Kits & Reagents Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Mycoplasma Testing Kits & Reagents Market Value (USD Million) By Region

Table 10: Global Mycoplasma Testing Kits & Reagents Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Mycoplasma Testing Kits & Reagents Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Mycoplasma Testing Kits & Reagents Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Mycoplasma Testing Kits & Reagents Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Thermo Fisher Scientific Basic Information And Sales Area

Table 31: Thermo Fisher Scientific. Products Portfolio

Table 32: Merck KGaA Basic Information And Sales Area

Table 33: Merck KGaA. Products Portfolio

Table 34: Lonza Group Ltd. Basic Information And Sales Area

Table 35: Lonza Group Ltd.. Products Portfolio

Table 36: PromoCell GmbH Basic Information And Sales Area

Table 37: PromoCell GmbH. Products Portfolio

Table 38: ATCC (American Type Culture Collection) Basic Information And Sales Area

Table 39: ATCC (American Type Culture Collection). Products Portfolio

Table 40: Charles River Laboratories International, Inc. Basic Information And Sales Area

Table 41: Charles River Laboratories International, Inc.. Products Portfolio

Table 42: Bionique Testing Laboratories, Inc. Basic Information And Sales Area

Table 43: Bionique Testing Laboratories, Inc.. Products Portfolio

Table 44: Biological Industries Israel Beit Haemek Ltd. Basic Information And Sales Area

Table 45: Biological Industries Israel Beit Haemek Ltd.. Products Portfolio

Table 46: InvivoGen Basic Information And Sales Area

Table 47: InvivoGen. Products Portfolio

Table 48: Global Market Value (USD Million) (2025-2032) By Application

Table 49: Global Market Share (%) By Application (2032)

Table 50: Global Market Value (USD Million) (2025-2032) By Types

Table 51: Global Market Share (%) By Types (2032)

Table 52: Global Mycoplasma Testing Kits & Reagents Market Value (USD Million) By Region

Table 53: Global Mycoplasma Testing Kits & Reagents Market Share (%) By Region (2025-2032)

Table 54: North America Market Value (USD Million) (2025-2032) By Country

Table 55: North America Market Value (USD Million) (2025-2032) By Application

Table 56: North America Market Value (USD Million) (2025-2032) By Types

Table 57: Europe Market Value (USD Million) (2025-2032) By Country

Table 58: Europe Market Value (USD Million) (2025-2032) By Application

Table 59: Europe Market Value (USD Million) (2025-2032) By Types

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 61: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 63: South America Market Value (USD Million) (2025-2032) By Country

Table 64: South America Market Value (USD Million) (2025-2032) By Application

Table 65: South America Market Value (USD Million) (2025-2032) By Types

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 67: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 69: Research Programs/Design For This Report

Table 70: Key Data Information From Secondary Sources

Table 71: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Mycoplasma Testing Kits & Reagents Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Merck KGaA; Lonza Group Ltd.; PromoCell GmbH; ATCC (American Type Culture Collection); Charles River Laboratories International, Inc.; Bionique Testing Laboratories, Inc.; Biological Industries Israel Beit Haemek Ltd.; InvivoGen
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Mycoplasma Testing Kits & Reagents market is poised for significant growth, driven by various factors. The market dynamics can be understood by examining the following key aspects:

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Mycoplasma Testing Kits & Reagents Segmentation Breakdown13 items

Application

Academic Research Institutes

Cell Banks

Contract Research Organizations

Pharmaceutical & Biotechnology Companies

Others

Types

PCR Assays

Nucleic Acid Detection Kits

Stains

Elimination Kits

Standards & Controls

Others

Regional Insights

Loading chart…

Competitive Landscape

Thermo Fisher Scientific: regional expansion

Merck KGaA: innovation pipeline

Lonza Group Ltd.: premium pricing

PromoCell GmbH: OEM tie-ups

ATCC: local manufacturing

Charles River Laboratories: vertical integration

Key Mycoplasma Testing Kits & Reagents Companies9 items

Thermo Fisher Scientific

Merck KGaA

Lonza Group Ltd.

PromoCell GmbH

ATCC (American Type Culture Collection)

Charles River Laboratories International, Inc.

Bionique Testing Laboratories, Inc.

Biological Industries Israel Beit Haemek Ltd.

InvivoGen

Market Ecosystem

Raw material/component suppliers — providing critical components

OEMs / manufacturers — designing and producing testing kits

Technology providers — developing innovative detection technologies

Distributors / channel partners — delivering products to end users

Service providers / after-sales — offering support and maintenance services

End users / buyers — utilizing testing kits and reagents

Regulators/standards bodies — establishing guidelines and standards

Recent Industry Insights

Analyst Overview

Table of Contents